Professor James McMahon is the Chief Research and Innovation Officer at the Royal Melbourne Hospital and an Infectious Diseases physician.
He is a clinician researcher with specific interests in HIV Cure including trials developing non-invasive imaging methods to locate and quantify tissue sites of HIV and clinical trials of interventions targeting the HIV reservoir with latency reversal agents and immunotherapeutics.
He also leads an adaptive randomised trial of COVID-19 vaccine boosting strategies in immunocompromised hosts and a large prospective study of immune responses to COVID vaccines in immunocompromised populations.
He is also the current President of ASHM, the peak organisation supporting the HIV, blood borne virus and sexual health clinical workforce.